WINDSOR, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- #" DuMOL Logo DuMOL Logo
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers 17-06-2024, 17:00